rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
42
|
pubmed:dateCreated |
2010-9-21
|
pubmed:abstractText |
In June 2009, we conducted a prospective study in Singapore on 51 individuals to determine their serologic responses before and following receipt of the 2009 Southern Hemisphere seasonal influenza vaccine.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1873-2518
|
pubmed:author |
pubmed-author:COEM RMR,
pubmed-author:ChenMark I CMI,
pubmed-author:ChowVincent T KVT,
pubmed-author:KellyPaul MPM,
pubmed-author:LeeCynthia X XCX,
pubmed-author:LeeVernon JVJ,
pubmed-author:LeoYee SinYS,
pubmed-author:LinRaymond TRT,
pubmed-author:PhoonM CMC,
pubmed-author:SakharkarK RKR,
pubmed-author:SakharkarM KMK,
pubmed-author:TanYee JooYJ,
pubmed-author:TayJoshua KJK,
pubmed-author:WeiL JLJ,
pubmed-author:WuYY,
pubmed-author:YapJonathanJ
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
4
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6852-7
|
pubmed:meshHeading |
pubmed-meshheading:20723626-Adult,
pubmed-meshheading:20723626-Antibodies, Neutralizing,
pubmed-meshheading:20723626-Antibodies, Viral,
pubmed-meshheading:20723626-Antibody Formation,
pubmed-meshheading:20723626-Cross Protection,
pubmed-meshheading:20723626-Cross Reactions,
pubmed-meshheading:20723626-Epitopes, B-Lymphocyte,
pubmed-meshheading:20723626-Humans,
pubmed-meshheading:20723626-Influenza, Human,
pubmed-meshheading:20723626-Influenza A Virus, H1N1 Subtype,
pubmed-meshheading:20723626-Influenza Vaccines,
pubmed-meshheading:20723626-Male,
pubmed-meshheading:20723626-Middle Aged,
pubmed-meshheading:20723626-Neutralization Tests,
pubmed-meshheading:20723626-Prospective Studies,
pubmed-meshheading:20723626-Vaccines, Inactivated,
pubmed-meshheading:20723626-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains.
|
pubmed:affiliation |
Biodefence Center, Singapore Armed Forces, 701 Transit Road #04-01, Singapore 778910, Singapore. vernonljm@hotmail.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|